Covidien Acquires BARRX Medical for $325,000,000

  • Feed Type
  • Date
    11/21/2011
  • Company Name
    BARRX Medical
  • Mailing Address
    540 Oakmead Parkway Sunnyvale, CA 94085
  • Company Description
    BARRX Medical, Inc. develops treatment solutions for Barrett’s esophagus, a precancerous condition of the lining of the esophagus (swallowing tube) caused by gastroesophageal reflux disease, or GERD.
  • Website
    http://www.barrx.com
  • Transaction Type
    M&A
  • Transaction Amount
    $325,000,000
  • Transaction Round
  • Proceeds Purposes
  • M&A Terms
    Covidien will acquire all of the outstanding capital stock of BÂRRX, a private company, for approximately $325 million, with future earn out payments possible based on achievement of specific milestones.

By posting a comment, you agree to our terms and conditions.